Pasithea Therapeutics Corp.
SEC CIK 1841330 · KTTA · last insider filing 2026-06-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Steinman Lawrence | Director | filed 2021 - 2026 |
| Novak Alfred J | Director | filed 2022 - 2026 |
| Leahy Emer | Director | filed 2021 - 2026 |
| Marques Tiago | Director · Chief Executive Officer | filed 2021 - 2026 |
| Dumesnil Simon | Director | filed 2021 - 2026 |
| Bendiabdallah Yassine | Director · Chief Operating Officer | filed 2021 - 2021 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Schneiderman Daniel H | Interim Chief Accting Officer | filed 2022 - 2026 |
| Krishnan Kartik | Chief Medical Officer | filed 2026 - 2026 |
| Currie Graeme Martin | Chief Development Officer | filed 2023 - 2024 |
| Gloss Stanley | Chief Financial Officer | filed 2021 - 2021 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.